Leaving BNY Website

 

You are leaving the BNY Mellon's Depositary Receipts' Website.
Linked sites are not under the control of The Bank of New York Mellon Corporation or any of its subsidiaries or affiliates (together, the "Company") and the Company is not responsible for the content of any linked site or any link contained in a linked site. If you choose to link to a website not controlled by the Company, you do so entirely at your own risk and the Company makes no warranties, either express or implied, concerning the content of such site, including the accuracy, completeness, reliability or suitability thereof for any particular purpose, nor does the Company warrant that such site or content is free from any claims of copyright, trademark or other infringement of the rights of third parties or that such site or content is devoid of viruses or other contamination. The Company does not guarantee the authenticity of documents on the Internet. Links to other sites do not imply any endorsement of or responsibility for the opinions, ideas, products, information or services offered at such sites, or any representation regarding the content at such sites. The Company reserves the right to terminate any link at any time.

Do you wish to continue to the linked site on these terms?

Stay On Page
Leave Page

© 2025 The Bank of New York Mellon Corporation

Depositary Receipt business and services are conducted through The Bank of New York Mellon.

BNY - DR Legal Disclaimer
  

To learn more about DRs, please contact DRBrokerSolutions@bny.com.

 

The information and data provided herein are provided for general informational purposes only.  BNY does not warrant or guarantee the accuracy, timeliness or completeness of any such information or data.  BNY does not undertake any obligation to update or amend any information or data, and may change, update or amend any information or data at any time without prior notice.

 

BNY provides no advice, recommendation or endorsement with respect to any company or securities.  No information or data is intended to provide legal, tax, accounting, investment, financial, trading or other advice on any matter, and is not to be used as such.  We expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon any information or data, including market value loss on the sale or purchase of securities or other instruments or obligations.

 

Nothing herein shall be deemed to constitute an offer to sell or a solicitation of an offer to buy securities.

 

BNY collects fees from DR holders pursuant to the terms and conditions of the DRs and any deposit agreement under which they are issued.  From time to time, BNY may make payments to an issuer to reimburse and/or share revenue from the fees collected from DR holders, or waive fees and expenses to an issuer for services provided, generally related to costs and expenses arising out of establishment and maintenance of the DR program.  BNY may pay a rebate to brokers in connection with unsponsored DR issuances; brokers may or may not disclose or pass back some or all of such rebate to the DR investor.  BNY may also use brokers, dealers or other service providers that are affiliates and that may earn or share fees and commissions.

 

BNY may execute DR foreign currency transactions itself or through its affiliates, or the Custodian or the underlying Company may execute foreign currency transactions and pay US dollars to BNY.  In those instances where it executes DR foreign currency transactions itself or through its affiliates, BNY acts as principal counterparty and not as agent, advisor, broker or fiduciary.  In such cases, BNY  has no obligation to obtain the most favorable exchange rate, makes no representation that the rate is a favorable rate and will not be liable for any direct or indirect losses associated with the rate. BNY earns and retains revenue on its executed foreign currency transactions based on, among other things, the difference between the rate it assigns to the transaction and the rate that it pays and receives for purchases and sales of currencies when buying or selling foreign currency for its own account.  The methodology used by BNY to determine DR conversion rates is available to registered Owners upon request or can be accessed here.  In those instances where BNY's Custodian executes DR foreign currency transactions, the Custodian has no obligation to obtain the most favorable exchange rate or that the method by which the rate will be determined will be the most favorable rate, and BNY makes no representation that the rate is a favorable rate and will not be liable for any direct or indirect losses associated with the rate.  In certain instances, BNY may receive dividends and other distributions from an issuer of securities underlying DRs in U.S. dollars rather than in a foreign currency.  In such cases, BNY will not engage in or be responsible for any foreign currency transactions and it makes no representation that the rate obtained by an issuer is a favorable rate and it will not be liable for any direct or indirect losses associated with the rate.

 

BNY is a global investments company dedicated to helping its clients manage and service their financial assets throughout the investment lifecycle.  BNY is the corporate brand of The Bank of New York Mellon Corporation (NYSE: BK).

 

BNY's name, brand and/or trademarks may not be used, copied or reproduced without the prior express written consent of BNY.

 

DEPOSITARY RECEIPTS ARE NOT INSURED BY THE FDIC OR ANY OTHER GOVERNMENT AGENCY, ARE NOT DEPOSITS OR OTHER OBLIGATIONS OF, AND ARE NOT GUARANTEED BY, BNY AND ARE SUBJECT TO INVESTMENT RISKS INCLUDING POSSIBLE LOSS OF PRINCIPAL AMOUNT INVESTED.

 

Please also see "Terms of Use."

ACCEPT

Please enable cookies in your browser if you wish to proceed.

Regulation S Disclaimer

 

Access To This Company Profile Is Restricted To Non-U.S. Persons Outside The United States Within The Meaning Of Regulation S Under The U.S. Securities Act Of 1933, As Amended (The "Securities Act").1

 

This company profile does not constitute an offer to sell or the solicitation of an offer to buy any securities in any jurisdiction or under any circumstances in which such offer or solicitation is unlawful.

 

Each person accessing this company profile, by so doing, will be deemed to have acknowledged that: (1) It is not a U.S. person (within the meaning of Regulation S under the Securities Act) and is located outside the U.S. (within the meaning of Regulation S under the Securities Act); and (2) Any securities described herein (A) have not been and will not be registered under the Securities Act or with any securities regulatory authority of any state or other jurisdiction and (B) may not be offered, sold, pledged or otherwise transferred except to persons outside the U.S. in accordance with Regulation S under the Securities Act pursuant to the terms of such securities.

 

If you agree with and accept the foregoing and the Terms of use governing this site, please select "Accept" below. Otherwise, press "Decline" to return to the previous page.

 

1 As defined in the Securities Act, the term "U.S Person" means: (1) any natural person resident in the United States; (2) any partnership or corporation organized or incorporated under the laws of the United States; (3) any estate of which any executor or administrator is a U.S. person; (4) any trust of which any trustee is a U.S. person; (5) any agency or branch of a foreign entity located in the United States; (6) any non-discretionary account or similar account (other than an estate or trust) held by a dealer or other fiduciary for the benefit or account of a U.S. person; (7) any discretionary account or similar account (other than an estate or trust) held by a dealer or other fiduciary organized, incorporated, or (if an individual) resident in the United States; and (8) any partnership or corporation if: (A) organized or incorporated under the laws of any foreign jurisdiction; and (B) formed by a U.S. person principally for the purpose of investing in securities not registered under the Securities Act, unless it is organized or incorporated, and owned, by accredited investors (as defined in Rule 501(a)) who are not natural persons, estates or trusts.

I Accept Decline

© 2024 The Bank of New York Mellon Corporation
Depositary Receipt business and services are conducted through The Bank of New York Mellon.

Back to Daily DR Market Summary

StreetAccount Summary - EU Market Recap: FTSE 100 (0.42%) to 9735.78, DAX (1.31%) to 23734.02, CAC40 (1.36%) to 7964.77, STOXX 600 (0.70%) to 567.90

Nov 06 ,2025

  • Synopsis:

    • European equity markets closed in negative territory and around the lowest level of the session. Basic Resources, Health Care and Real Estate were the best performing sectors. Technology, Industrial Goods&Servicecs and Media lagged. Follows positive close on Wednesday. Stoxx Europe 600 still well off Tuesday's two-week lows, now just slightly lower on the week.

    • Central bank policy a focal point in Europe. BoE left policy on hold in narrow 5-4 vote split but highlighted rates likely on gradual downward path and inflation risks now more balanced. Norges Bank left policy on hold as expected. Anticipates further rate cuts in the coming year if economy evolves as it expects.

    • On the macro data front, German industrial production rose 1.3% m/m in Sep, recovering from Aug's 3.7% decline. However, rebound masks persistent structural weaknesses, with production still down 1.0% y/y. Sep recovery primarily driven by sharp 12.3% surge in automotive production, rebounding from Aug's 16.7% decline caused by annual plant closures and production changeovers. While production expectations show some improvement, structural challenges including US tariffs, Chinese competition, and capacity utilisation at financial-crisis levels suggest any recovery will be modest and cyclical. Oct manufacturing PMI remained in contraction at 49.6, with employment declining for the 28th consecutive month, underscoring Germany's persistent industrial struggles.

    • Amidst a busy earnings calendar, DACH names kicked off the session, with Zurich Insurance Group (ZUNR.SW), DHL Group (DHL.GR), Commerzbank (CBK.GR), Continental (CON.GR), Adecco Group (ADEN.SW), Henkel (HEN3.GR), Deutz (DEZ.GR), Swisscom (SCMN.SW), Zalando (ZAL.GR) and SÜSS MicroTec (SMHN.GR) updating investors before the open. In n France, Worldline (WLN.FP) posted a CMD update and confirmed a capital increase of €500M; Air France (AF.FP), Teleperformance (TEP.FP), Legrand (LR.FP) and Eurazeo (RF.FP) also reported earlier. In the UK, AstraZeneca (AZN.LN), Diageo (DGE.LN), BT Group (BT.A.LN), Tate & Lyle (TATE.LN), Smith & Nephew (SN.LN) and CRH (CRH.LN) were among few other names from the region to release updates whilst - in the Nordics - Maersk (MAERSK.B.DC), GN Store Nord (GNDC), DNO (DNO.NO) and DFDS (DFDS.DC) reported this morning, with the latter also lowering FY guidance, announcing a cost cutting program and commencing its CEO succession process. Of note, shares in Novo Nordisk (NOVO.B.DC) are trading +3% higher after a Delaware Chancery Court denied Pfizer's request for a temporary restraining order to block Metsera's Board of Directors from acting in the best interests of shareholders. Elsewhere, EDP-Energias de Portuga (EDP.PL), EDP Renovaveis (EDPR.PL), Iveco Group (IVG.IM). Diasorin (DIA.IM) Koninklijke BAM Groep (BAMNB.NA), AMG Critical Materials (AMG.NA) and Solvay (SOLB.BB) issued their Q3/9M numbers.

    • In M&A, Bavarian Nordic (BAVA.DC) shares closed (20.8%) lower after consortium consisting of Nordic Capital and Permira withdrew offer as minimum acceptance condition has not been satisfied

  • Digest:

    • Sectors - STOXX Europe 600:

      • Outperformers:

        • Basic Resources +0.66%, Health Care +0.41%, Real Estate +0.36%, Banks +0.35%, Utilities +0.26%, Telecom +0.15%, Insurance (0.51%), Retail (0.63%), Autos & Parts (0.65%), Oil & Gas (0.67%)

      • Underperformers

        • Technology (1.88%), Ind Goods & Svcs (1.77%), Media (1.71%), Financial Svcs (1.70%), Travel & Leisure (1.62%), Construct & Mtls (1.42%), Persnl & HHold Goods (1.29%), Food & Beverage (0.91%), Chemicals (0.80%),

    • Macro:

      • Central Banks

        • Bank of England keeps rates on hold at 4% in knife-edge decision - FT

        • Norway central bank keeps rates on hold, as expected - Reuters

      • EU

        • Brussels tweaks budget overhaul in bid to stave off parliament rebellion - FT

        • EU Faces Pressure to Provide Credible Funding Plan for Ukraine - Bloomberg

      • UK

        • Think-tank linked to Reform UK says Britain is heading for debt crisis - FT

        • Reeves set to spare UK banks from Budget tax raid - FT

        • Rachel Reeves 'planning pay-per-mile tax for electric vehicles in budget' - The Guardian

        • Sainsbury's says shoppers are delaying spending in run-up to budget - Guardian

      • France

        • France Asks EU to Probe Shein, Act Over Sex Dolls, Weapons - Bloomberg

      • Germany

        • Production in Germany increases - Handelsblatt

        • Government reactivates new construction subsidy with 800 million euros - Handelsblatt

    • Company news:

      • Notable Gainers

        • +37.8% CTNK.GR (centrotherm international €6.75, +1.85) -- Solarpark Blautal GmbH sells majority stake in centrotherm international AG to the investment company ARDIAN

        • +32.8% FORSE.FP (Forsee Power €0.35, +0.09) -- Rolls-Royce (RR.LN) strategic partnership; transfer of listing

        • +24.3% PHARM.NA (Pharming Group €1.37, +0.27) -- earnings

        • +22.5% HARVIA.FH (Harvia €42.95, +7.90) -- earnings

        • +20.9% NEL.NO (NEL ASA NOK2.62, +0.45) -- purchase order

        • +19.4% NETI.B.SS (Net Insight SEK4.37, +0.71) -- earnings

        • +17.3% MNTC.SS (Mentice SEK11.00, +1.62) -- earnings

        • +16.9% ALCRB.FP (Carbios €8.36, +1.21) -- collaboration agreement

        • +16.0% VRCI.LN (Verici Dx £0.01, -0.00) -- agreement

        • +13.7% BIOV.SW (BioVersys CHF25.80, +3.10) -- doses first subject in Phase 1 clinical trial with BV100 in China

        • +13.5% TEKNA.NO (Tekna Holding NOK4.20, +0.50) -- earnings

        • +13.5% AUTO.NO (AutoStore Holdings NOK11.00, +1.31) -- earnings

        • +12.9% SMHN.GR (SÜSS MicroTec €30.10, +3.44) -- earnings

        • +10.8% HTWS.LN (Helios Towers £1.72, +0.17) -- earnings; strategy; buyback

        • +9.8% APOTEA.SS (Apotea SEK89.45, +7.98) -- earnings

        • +9.5% FDEV.LN (Frontier Developments £5.63, +0.49) -- franchise update

        • +9.2% BRE.IM (Brembo €9.96, +0.84) -- Q3 earnings

        • +8.6% DHL.GR (DHL Group €43.32, +3.44) -- earnings

        • +8.5% WG.LN (John Wood Group £0.20, +0.02) -- restored to listing and trading on the Main Market of LSE

        • +7.7% RS1.LN (RS Group plc £5.95, +0.43) -- earnings

        • +7.5% DIS.IM (D'Amico International Shipping €4.84, +0.34) -- Q3 earnings

        • +7.2% TPG.GR (Platform Group €8.36, +0.56) -- earnings

        • +7.0% NSIS.B.DC (Novonesis DKK415.00, +27.10) -- earnings

        • +6.6% ZAL.GR (Zalando €24.14, +1.49) -- earnings

        • +6.3% ADEN.SW (Adecco Group CHF24.18, +1.44) -- earnings; CFO steps down

        • +6.0% SGL.GR (SGL Carbon €3.00, +0.17) -- earnings

        • +5.7% HPHA.GR (Heidelberg Pharma €3.13, +0.17) -- lead ATAC candidate HDP-101 shows progress in Phase I/IIa trial in multiple myeloma

        • +5.2% WEW.GR (Westwing Group €12.25, +0.60) -- earnings

        • +5.2% VEI.NO (Veidekke NOK162.00, +8.00) -- earnings; contract

        • +5.1% BUSER.SS (Bambuser SEK0.54, +0.03) -- rights issue

        • +5.0% TRMED.NO (Thor Medical NOK3.71, +0.18) -- supply agreement

        • +5.0% AZM.IM (Azimut Holding €35.35, +1.68) -- Q3 earnings; updates on TNB & strategic plan and announces €500M buyback

        • +5.0% OSB.LN (OSB Group £5.53, +0.27) -- trading update

        • +4.5% HOT.GR (Hochtief €274.00, +11.80) -- raises FY operational net profit guidance; now expects to see an acceleration of operational net profit growth in Q4 versus the first nine-months 2025

        • +4.3% ASKER.SS (Asker Healthcare Group SEK91.22, +3.77) -- earnings

        • +3.8% TITC.BB (Titan S.A. €40.65, +1.50) -- exclusive negotiations to acquire Vracs de L'Estuaire in Northern France

        • +3.7% IMI.LN (IMI £24.92, +0.90) -- trading update

        • +3.6% CAPMAN.FH (Capman €1.85, +0.06) -- earnings

        • +3.5% PDL.LN (Petra Diamonds £0.19, +0.01) -- shareholders approve rights issue

        • +3.4% SYENS.BB (Syensqo €70.36, +2.30) -- earnings

        • +3.4% PION.B.SS (PION Group SEK6.00, +0.20) -- earnings

        • +3.3% AMUN.FP (Amundi €66.40, +2.10) -- State Bank of India approves divesting 32.1M SBI Funds Management shares, or 6.3% stake, via IPO

        • +3.3% WOSG.LN (Watches of Switzerland Group £4.03, +0.13) -- trading update

      • Notable Decliners

        • -25.9% RSGN.SW (R&S Group Holding CHF18.82, -6.58) -- guidance

        • -20.8% BAVA.DC (Bavarian Nordic A/S DKK187.00, -49.00) -- Consortium consisting of Nordic Capital and Permira withdraws offer for Bavarian Nordic A/S as minimum acceptance condition has not been satisfied

        • -18.8% DIA.IM (Diasorin €60.32, -13.94) -- earnings

        • -17.4% SESG.FP (SES €5.30, -1.12) -- earnings

        • -16.8% HEX.NO (Hexagon Composites NOK7.31, -1.48) -- earnings

        • -16.4% NFG.LN (Next 15 Group £3.16, -0.62) -- terminates discussions related to sale of brands

        • -16.1% RUG.SS (Rugvista Group SEK67.60, -13.00) -- earnings

        • -14.9% AF.FP (Air France-KLM €10.01, -1.75) -- earnings

        • -14.1% HIK.LN (Hikma Pharmaceuticals £15.22, -2.49) -- trading statement; STARJEMZA (ustekinumab-hmny) injection launch

        • -12.3% LXS.GR (Lanxess €17.04, -2.39) -- earnings

        • -12.2% LR.FP (Legrand €129.25, -17.95) -- earnings; Deutsche Bank downgrade

        • -11.9% TBCG.LN (TBC Bank Group £37.85, -5.10) -- earnings

        • -10.9% MEDCL.FP (MedinCell €31.64, -3.88) -- TPICAP Midcap downgrade

        • -10.9% SN.LN (Smith & Nephew £12.42, -1.52) -- sales

        • -9.5% GF.SW (Georg Fischer CHF51.40, -5.40) -- UBS downgrade

        • -9.3% WLN.FP (Worldline €1.86, -0.19) -- CMD update; confirms capital increase of €500M

        • -9.1% VCP.LN (Victoria £0.50, -0.05) -- trading update

        • -9.1% CEVI.SS (CellaVision SEK160.00, -16.00) -- earnings

        • -7.7% LNZ.AV (Lenzing €22.90, -1.90) -- earnings

        • -7.4% IMCD.NA (IMCD €82.24, -6.54) -- earnings

        • -7.1% SFOR.LN (S4 Capital £0.20, -0.02) -- earnings

        • -6.5% DFDS.DC (DFDS DKK85.75, -6.00) -- earnings; CEO succession; cost reduction

        • -6.5% DGE.LN (Diageo £16.80, -1.18) -- trading statement

        • -6.4% EDP.PL (EDP-Energias de Portugal €4.11, -0.28) -- earnings; business plan

        • -6.4% AZT.NO (ArcticZymes Technologies NOK26.20, -1.80) -- earnings

        • -6.1% BYW6.GR (BayWa €5.05, -0.33) -- divestment

        • -5.9% CEM.IM (Cementir Holding €14.58, -0.92) -- 9M earnings

        • -5.9% MTLN.GA (Metlen Energy & Metals Plc €43.00, -2.68) -- sales

        • -5.9% CAMX.SS (Camurus SEK554.00, -34.50) -- earnings

        • -5.9% HWDN.LN (Howden Joinery Group £8.20, -0.51) -- trading update

        • -5.6% HABA.GR (Hamborner REIT €4.83, -0.29) -- earnings

        • -5.4% AENA.SM (Aena S.M.E. €22.44, -1.28) -- Sustainable Mobility Bill potential effect

        • -5.4% HFG.GR (HelloFresh €5.96, -0.34) -- Grizzly Research short report

        • -5.3% MAERSK.B.DC (Maersk DKK12,845.00, -725.00) -- earnings

        • -5.0% HEI.GR (Heidelberg Materials €196.75, -10.25) -- earnings

        • -4.8% SITOWS.FH (Sitowise Group €2.38, -0.12) -- earnings

        • -4.7% SKA.B.SS (Skanska SEK249.00, -12.30) -- earnings

        • -4.7% ONCO.SS (Oncopeptides SEK4.78, -0.23) -- reinstated hold at DNB Carnegie

        • -4.5% GREAT.SS (Greater Than SEK19.10, -0.90) -- Q3 earnings

        • -3.7% NEX.FP (Nexans €121.00, -4.60) -- consortium

        • -3.0% ASC.IM (Ascopiave €3.11, -0.10) -- 9M earnings

        • -2.5% KID.NO (Kid ASA NOK133.00, -3.40) -- earnings

        • -2.3% CRH.LN (CRH plc £87.24, -2.04) -- earnings

        • -2.1% FYNBK.DC (Fynske Bank DKK186.00, -4.00) -- Q3 earnings

    • EU companies reporting tomorrow:

      • Earnings:

        • Benelux: Proximus (PROX.BB), Aperam (APAM.NA)

        • DACHs: Daimler Truck Holding (DTG.GR), HENSOLDT (HAG.GR), Krones (KRN.GR), Stratec (SBS.GR), MAX Automation (MXHN.GR), Fabasoft (FAA.GR), Data Modul (DAM.GR), Global Fashion Group (GFG.GR)

        • France: Arkema (AKE.FP)

        • Nordics: RaySearch Laboratories (RAY.B.SS), Catella (CAT.B.SS), Genovis (GENO.SS), Arla Plast (ARPL.SS), Novotek (NTEK.B.SS), Oneflow (ONEF.SS), Sveafastigheter (SVEAF.SS), Samhällsbyggnadsbolaget i Norden (SBB.B.SS), Arendals Fossekompani (AFK.NO), Hofseth BioCare (HBC.NO)

        • Southern Europe: Amadeus IT Group (AMS.SM), Cellnex Telecom (CLNX.SM), Alpha Bank (ALPHA.GA), Piaggio & C (PIA.IM), SECO (IOT.IM), Banca Sistema (BST.IM)

        • UK: International Consolidated Airlines Group (IAG.LN), Record (REC.LN)

        • Other: MOL Hungarian Oil & Gas (MOL.HB)

      • Trading Update:

        • Benelux: InPost (INPST.NA), Sif Holding (SIFG.NA)

        • France: Hexaom (ALHEX.FP)

        • Nordics: Gubra (GUBRA.DC), HusCompagniet (HUSCO.DC)

  • Data:

    • Economics:

      • Germany

        • Sep Industrial Production +1.3% m/m vs consensus +3.0% and prior revised (3.7%) from (4.3%)

        • Oct Construction PMI 42.8 vs consensus 46.9 and prior 46.2

      • Sweden Oct CPI +0.9% y/y vs consensus +0.8% and prior +0.9%

      • Switzerland Oct Unemployment Rate (sa) 3.0% vs consensus 3.0% and prior 3.0%

      • Spain Sep Industrial Production +1.7% y/y vs consensus +2.5% and prior revised +3.3% from +3.4%

      • Eurozone Sep Retail Sales +1.0% y/y vs consensus +1.0% and prior revised +1.6% from +1.0%

      • UK Oct Construction PMI 44.1 vs consensus 46.7 and prior 46.2

    • Markets:

      • WTI Crude (Dec 25): ($0.28) or (0.47%) to $59.32

      • €-$ +0.0047 or +0.41% to 1.1541

      • £-$ +0.0058 or +0.45% to 1.3109

      • €-£ (0.0001) to 0.8806

      • S&P 500 (1.13%)

      • Performance year-to-date

        • FTSE 100: +19.12%

        • DAX: +19.21%

        • CAC: +7.91%

        • MIB: +25.98%

        • Stoxx 600: +11.88%

This information and data is provided for general informational purposes only. The Bank of New York Mellon and our information suppliers do not warrant or guarantee the accuracy, timeliness or completeness of this information or data. We provide no advice nor recommendation or endorsement with respect to any company or securities. We do not undertake any obligation to update or amend this information or data. Nothing herein shall be deemed to constitute an offer to sell or a solicitation of an offer to buy securities.
Please refer to "Terms Of Use".

DEPOSITARY RECEIPTS:
NOT FDIC, STATE OR FEDERAL AGENCY INSURED
MAY LOSE VALUE
NO BANK, STATE OR FEDERAL AGENCY GUARANTEE